Xu [28] analyzed 80 prostate cancer patients as well as 351 prostate cancer patients from The Cancer Genome Atlas (TCGA) and found that abnormal Rad50 gene expression correlated significantly with the invasive progression and low survival rate of this type of cancer. This evidence concerns the gene RAD50 and prostate carcinoma.